CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Q4 2024 Earnings Call Transcript January 22, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.04, ...

In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.

Kelsey Warren [email protected]  609 218 4053 Investor contact: Lauren Johnson [email protected] ...

It has been used as a party drug for decades but is an “approved medical product as an injectable, short-acting anesthetic for use in humans and animals and as a nasal spray (Spravato ...

Revolutionizing Postoperative Recovery The advantages of surgical navigation systems extend beyond the operating room, contributing to advancements in the recovery phase. By supporting minimally ...

Details of Auchincloss’s medical recovery came as BP said in an update ahead of full-year figures that upstream oil and gas production in the fourth quarter was lower than the previous three ...

Details of Mr Auchincloss’s medical recovery came as BP said in an update ahead of full-year figures that upstream oil and gas production in the fourth quarter was lower than the previous three ...